Cornerstone Financial Partners LLC Has $2.32 Million Holdings in SPDR S&P Biotech ETF (XBI)

Cornerstone Financial Partners LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 36.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,780 shares of the exchange traded fund’s stock after selling 15,404 shares during the quarter. Cornerstone Financial Partners LLC owned about 0.05% of SPDR S&P Biotech ETF worth $2,317,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in XBI. Quantitative Investment Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 642.3% during the second quarter. Quantitative Investment Management LLC now owns 1,451,998 shares of the exchange traded fund’s stock valued at $112,065,000 after buying an additional 1,256,398 shares during the last quarter. Assetmark Inc. lifted its position in shares of SPDR S&P Biotech ETF by 59.9% during the third quarter. Assetmark Inc. now owns 1,239,051 shares of the exchange traded fund’s stock valued at $107,265,000 after buying an additional 464,246 shares during the last quarter. SG Americas Securities LLC lifted its position in shares of SPDR S&P Biotech ETF by 162.8% during the third quarter. SG Americas Securities LLC now owns 303,622 shares of the exchange traded fund’s stock valued at $26,285,000 after buying an additional 188,106 shares during the last quarter. NF Trinity Capital Hong Kong Ltd purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $10,302,000. Finally, Tavio Capital LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $10,027,000.

COPYRIGHT VIOLATION NOTICE: “Cornerstone Financial Partners LLC Has $2.32 Million Holdings in SPDR S&P Biotech ETF (XBI)” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/11/24/cornerstone-financial-partners-llc-has-2-32-million-holdings-in-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF (NYSEARCA:XBI) traded up $0.43 during mid-day trading on Friday, hitting $81.71. 2,376,500 shares of the company’s stock traded hands, compared to its average volume of 4,221,887. SPDR S&P Biotech ETF has a 1-year low of $58.66 and a 1-year high of $88.98.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply